论文部分内容阅读
消化性溃疡的内科治疗,药物甚多,由制酸剂及抗乙酰胆硷药发展到H2受体拮抗剂,Na—K泵抑制剂。有的药物疗效满意,但复发率高,副作用大,现选用了利福平、痢特灵、锡类散用于临床,应用后的观察,总结如下:一、临床资料〈1〉病人选择:自1985—1988年随机选择,经X检查诊断为疡溃病后,又做胃镜,病理证实为消化性溃疡51例干部31人、工人20人、男41人、女10人。年龄在18—59岁之间。病程1—9年。溃疡面在0.5—2cm之间,其中6例溃疡伴出血。除外癌性溃疡和应激性溃疡。病人分三组,每组17人。
Peptic ulcer medical treatment, many drugs, from antacids and anti-acetylcholine drugs developed H2 receptor antagonists, Na-K pump inhibitor. Some drugs are satisfactory, but the recurrence rate is high, side effects, the selection of rifampicin, furazolidone, tin class for clinical use, the observation after the application, summarized as follows: First, the clinical data <1> Patient Selection: From 1985 to 1988, a random selection, diagnosed by X-ray ulcer disease, but also gastroscopy, pathology confirmed peptic ulcer in 51 cases of cadres and 31 workers, 20 people, 41 males and 10 females. Between the ages of 18-59. Duration of 1 - 9 years. Ulcers 0.5-2cm in between, of which 6 cases of ulcers with bleeding. Except for cancerous ulcers and stress ulcers. Patients were divided into three groups, each group of 17 people.